ATE133074T1 - Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen - Google Patents

Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen

Info

Publication number
ATE133074T1
ATE133074T1 AT91906129T AT91906129T ATE133074T1 AT E133074 T1 ATE133074 T1 AT E133074T1 AT 91906129 T AT91906129 T AT 91906129T AT 91906129 T AT91906129 T AT 91906129T AT E133074 T1 ATE133074 T1 AT E133074T1
Authority
AT
Austria
Prior art keywords
immune response
agents
boost
inducing
mammals
Prior art date
Application number
AT91906129T
Other languages
English (en)
Inventor
Jerome A East Th Stre Schwartz
Claude H Nash
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE133074T1 publication Critical patent/ATE133074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT91906129T 1990-03-21 1991-03-19 Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen ATE133074T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49683290A 1990-03-21 1990-03-21

Publications (1)

Publication Number Publication Date
ATE133074T1 true ATE133074T1 (de) 1996-02-15

Family

ID=23974340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906129T ATE133074T1 (de) 1990-03-21 1991-03-19 Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen

Country Status (19)

Country Link
EP (1) EP0521916B1 (de)
JP (1) JPH05505799A (de)
CN (1) CN1055116A (de)
AT (1) ATE133074T1 (de)
AU (1) AU656889B2 (de)
CA (1) CA2078676A1 (de)
DE (1) DE69116552T2 (de)
DK (1) DK0521916T3 (de)
ES (1) ES2082201T3 (de)
FI (1) FI924215A0 (de)
GR (1) GR3019018T3 (de)
HU (1) HUT63062A (de)
IE (1) IE72204B1 (de)
IL (1) IL97600A0 (de)
MY (1) MY108672A (de)
OA (1) OA09672A (de)
PT (1) PT97082B (de)
WO (1) WO1991014450A1 (de)
ZA (1) ZA912037B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100191223B1 (ko) * 1989-07-28 1999-06-15 둘락 노먼 씨. 인터루킨-4의 정제방법 및 이를 함유하는 약제학적 조성물
US7449186B1 (en) * 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
ATE129900T1 (de) * 1990-12-19 1995-11-15 Schering Corp Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
WO1992011861A1 (en) * 1991-01-10 1992-07-23 Schering Corporation Use of il-4 to enhance the reparative phase of wound healing and repair and to enhance the healing of infected wounds and the wounds of diabetic mammals
GB9124347D0 (en) * 1991-11-15 1992-01-08 Isis Innovation Treatment of macrophages
EP0656785B1 (de) * 1992-08-19 1998-03-11 Schering Corporation Methode zur inhibition von hiv-replikation mittels il-4

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
EP0302429B1 (de) * 1987-08-03 1993-07-28 Tasuku Honjo Menschliches Interleukin-4, Expressionsvektoren dafür und diese enthaltende Transformanten
JPH0236129A (ja) * 1988-07-22 1990-02-06 Ajinomoto Co Inc ワクチン効果増強剤
JPH0611706B2 (ja) * 1989-01-20 1994-02-16 ザ ユニバーシティ オブ メルボルン フィブリン溶解

Also Published As

Publication number Publication date
IE910921A1 (en) 1991-09-25
ES2082201T3 (es) 1996-03-16
IL97600A0 (en) 1992-06-21
MY108672A (en) 1996-10-31
AU7469091A (en) 1991-10-21
PT97082A (pt) 1991-11-29
DE69116552D1 (de) 1996-02-29
PT97082B (pt) 1998-07-31
CA2078676A1 (en) 1991-09-22
IE72204B1 (en) 1997-04-09
DE69116552T2 (de) 1996-05-30
CN1055116A (zh) 1991-10-09
FI924215A (fi) 1992-09-21
WO1991014450A1 (en) 1991-10-03
HUT63062A (en) 1993-07-28
EP0521916A1 (de) 1993-01-13
ZA912037B (en) 1992-03-25
AU656889B2 (en) 1995-02-23
JPH05505799A (ja) 1993-08-26
FI924215A0 (fi) 1992-09-21
DK0521916T3 (da) 1996-03-04
EP0521916B1 (de) 1996-01-17
OA09672A (en) 1993-05-15
GR3019018T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
DK641889A (da) Anvendelse af en blodpladeaktiveringsfaktorantagonist i kombination med monoklonale eller polyklonale antistoffer i et farmaceutisk praeparat til behandling af endotoksisk chok hos pattedyr
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
DE69130071D1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
ATE413191T1 (de) Verwendung of interleukin-1 mutein als impfstoffadjuvans
ATE133074T1 (de) Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen- herausforderungen
ITMI913092A1 (it) Vaccino di poxvirus ricombinante del virus del morbillo
DE69114519T2 (de) Anwendung von il-4 zur steigerung der immunantwort auf immunogene in impfstoffen.
DE3773295D1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
ATE229981T1 (de) Glykolisierte cytokine
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
ES2160927T3 (es) Composiciones farmaceuticas que comprenden interferon alfa humano natural.
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств